BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3094459)

  • 61. [Prospective controlled study on the usefulness of Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer].
    Yasutomi M; Takahashi T; Kodaira S; Hojo K; Kato T; Ogawa M; Ichihashi H; Tominaga T; Tamada R; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1953-60. PubMed ID: 9350242
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Results of a randomized trial with or without 5-FU-based preoperative chemotherapy followed by postoperative chemotherapy in resected colon and rectal carcinoma.
    Colorectal Cancer Chemotherapy Study Group of Japan - The 2nd Trial
    Jpn J Clin Oncol; 2003 Jun; 33(6):288-96. PubMed ID: 12913083
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Prospective adjuvant chemotherapy, with mitomycin C plus long-term carmofur in colorectal cancer].
    Terabe K; Yamauchi M; Watanabe T; Ichihashi H; Takagi H; Imaizumi M; Kondo T
    Gan No Rinsho; 1986 Mar; 32(3):261-7. PubMed ID: 3086597
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Intra-operative pelvic hyperthermochemotherapy combined with surgery in rectal cancer].
    Takahashi M; Fujimoto S; Takai M; Oohno K; Endoh F; Masuda Y; Masuda Y; Kobayashi N; Tanaka H; Obata G
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1604-6. PubMed ID: 2117892
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Prevention of peritoneal dissemination after colorectal surgery--significance of MMC administration in abdominal cavity].
    Kameyama M; Fukuda I; Imaoka S; Masutani S; Ohigashi H; Sasaki Y; Kabuto T; Ishikawa O; Furukawa H; Koyama H
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1808-11. PubMed ID: 1908656
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy].
    Ichihashi H; Yamauchi M; Watanabe T; Takagi H; Kondo T
    Gan No Rinsho; 1988 Apr; 34(4):451-6. PubMed ID: 3128670
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Missile therapy using monoclonal antibody drug conjugates in colorectal carcinoma].
    Takahashi T; Yamaguchi T; Yokota T; Kitamura K; Suzuyama H; Honda M; Otsuji E; Sawai K; Sakita M; Kotanagi H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):931-7. PubMed ID: 2952068
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical evaluation of intra-operative pelvic hyperthermochemotherapy combined with operation for rectal cancer].
    Takahashi M; Fujimoto S; Takai M; Ohno K; Endoh F; Masuda Y; Masuda Y; Obata G; Kokubun M; Kobayashi K
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):2024-7. PubMed ID: 1908667
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mitomycin C plus carmofur (HCFU) adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma (interim report).
    Niimoto M; Hattori T; Tamada R; Sugimachi K; Inokuchi K; Ogawa N
    Jpn J Surg; 1987 Sep; 17(5):354-61. PubMed ID: 3123756
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Surgery and adjuvant therapy of cancer of the large intestine].
    Yasutomi M
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2307-17. PubMed ID: 3089176
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Combination therapy of high dose doxifluridine (5'-DFUR)+mitomycin C (MMC) for advanced or recurrent colorectal cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs].
    Kikkawa N; Taguchi T; Sakai K; Irie K; Terasawa T; Shimoyama T; Iwanaga T; Fukuda I; Okumura S; Yasutake K
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):117-23. PubMed ID: 8422175
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Adjuvant parenteral nutrition in cytostatic chemotherapy].
    Heim ME
    Infusionsther Klin Ernahr; 1986 Jun; 13(3):115-21. PubMed ID: 3091499
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Outcome of adjuvant mifurol chemotherapy in patients with resected colonic carcinoma].
    Morioka Y; Muto T; Kusama S; Kimura T; Tomiyama J; Ogawa N
    Gan No Rinsho; 1989 Aug; 35(9):1031-41. PubMed ID: 2504972
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pelvic intra-arterial mitomycin C infusion in previously treated patients with metastatic, unresectable, pelvic colorectal cancer and angiographic determination of tumor vascularity.
    Tseng MH; Park HC
    J Clin Oncol; 1985 Aug; 3(8):1093-100. PubMed ID: 3926959
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Mitomycin C plus HCFU adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma. (Second report): 5-year survival rate. Cooperative Study Group of Kyushu and Chugoku for HCFU Adjuvant Chemotherapy].
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):333-9. PubMed ID: 2494948
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Blood levels of mitomycin C in patients given by various routes of administration].
    Kato T; Hirai T; Yasui K; Nakazato H; Suzuki H
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2639-44. PubMed ID: 2505685
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled, randomized trial.
    Grage TB; Moss SE
    Surg Clin North Am; 1981 Dec; 61(6):1321-9. PubMed ID: 6171898
    [No Abstract]   [Full Text] [Related]  

  • 78. [Appropriate duration of postoperative oral adjuvant chemotherapy with HCFU for colorectal cancer].
    Ito K; Okushiba S; Morikawa T; Kondo S; Katoh H
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):55-9. PubMed ID: 14750322
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chemotherapy as an adjuvant to surgery for colorectal cancer. A follow-up report.
    Lawrence W; Terz JJ; Horsley JS; Brown PW; Romero C
    Arch Surg; 1978 Feb; 113(2):164-8. PubMed ID: 343748
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical study of controlled-release preparation of mitomycin C in the treatment of inoperable cancer patients].
    Hanyu F; Nakamura M; Takasaki T; Kasai Y; Sato T; Sato H; Sakurai Y; Yamada A; Okawa T; Sakabe T
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3087-93. PubMed ID: 2461168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.